XCXuebing Cao

Xuebing Cao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xuebing Cao has a total of 153 co-authors. Here are the top co-authors by number of shared publications:

  • Yan Xu

    Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    16 shared publications
  • Weiqi Zeng

    Department of Neurology, The First People's Hospital of Foshan, Foshan 528000, China

    12 shared publications
  • Xiaoman Yang

    Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China

    11 shared publications
  • Yan Xu

    Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China

    11 shared publications
  • Shuke Nie

    Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China

    10 shared publications
  • Guiqin Chen

    Department of Neurology, Renmin Hospital of Wuhan University, Wuhan 430060, China

    9 shared publications

Latest Publications

  • Open Access

    Multi-omics analysis of hypoxia-mitochondrial energy metabolism and programmed cell death profiling in Parkinson’s disease

    by An Chang, Yi Wu, Piaopiao Lian, Zhuoran Ma, Zhicheng Tang, Haoxuan Ouyang, Maoyu Liu, Xuebing Cao, Heng Zhai, Yan Xu

    Hypoxia and mitochondrial energy metabolism (MEM) impairment are pivotal features of Parkinson’s disease (PD), yet the regulators linking hypoxic stress to mitochondrial failure remain elusive. Here we integrated multiple transcriptomic datasets from the substantia nigra to characterize the hypoxia and MEM landscape. Utilizing a tripartite machine learning framework combined with LASSO-logistic regression, we developed a robust seven-gene diagnostic model that achieved high predictive accuracy (AUC: 0.887 training; 0.821 validation). Two-sample Mendelian randomization (MR) analysis further identified seven causal genes (TTC19, SERPINA1, MPC2, DLK1, DDIT4, AUH, and ASL) associated with PD risk. By integrating programmed cell death (PCD) profiling and scRNA-seq, we discovered that core regulators MPC2 and AUH were uniquely associated with novel PCD modes, showing negative correlations with alkaliptosis and positive correlations with cuproptosis. Single-cell analysis localized primary hypoxia-MEM impairment to dopaminergic neurons (DaNs), where MPC2 expression was significantly depleted. In silico virtual knockout of MPC2 disrupted dopamine metabolism and synaptic vesicle cycles, while STAT3 and MEF2A were identified as potential upstream transcription factors linking metabolic dysfunction to neuroinflammation. Together, our findings identify MPC2 as a genetically supported causal regulator linking hypoxia-MEM failure to novel PCD in DaNs, offering potential biomarkers and therapeutic targets for precision intervention in PD.

  • Open Access

    Advanced Eye Movement Features Measured by Quantitative Oculography as Candidate Biomarkers for Progressive Supranuclear Palsy

    by Haoxuan Ouyang, Bo Liu, Qiwei Peng, Zhuoran Ma, Zhicheng Tang, An Chang, Maoyu Liu, Xuebing Cao, Yan Xu, Yun Xia

    Conventional qualitative eye movement examinations may miss subtle abnormalities, complicating early and accurate diagnosis of progressive supranuclear palsy (PSP). Quantitative oculography, represented by video-oculography (VOG), provides an objective digital assessment of eye movements. This review summarizes abnormalities in advanced eye movement tasks in PSP, including prosaccades (ProSs), antisaccades (ASs), memory-guided saccades (MGSs), predictive saccades (PSs), overlap saccades (OSs) and gap saccades (GSs), and considers their underlying pathophysiological mechanisms. Quantitative metrics from these tasks may help distinguish PSP subtypes and PSP from other neurodegenerative diseases, such as Parkinson’s disease (PD), multiple system atrophy (MSA), corticobasal degeneration (CBD) and Alzheimer’s disease (AD). Advanced eye movement measures are therefore promising candidate biomarkers for PSP diagnosis and longitudinal disease monitoring.

  • Open Access

    Chronic pain, depression, and cognitive trajectories in Chinese middle-aged and older adults: A longitudinal cohort study

    by Haoxuan Ouyang, Xiaoyu Kang, Yan Xu, Yi Wu, Zhuoran Ma, Zhicheng Tang, An Chang, Maoyu Liu, Heng Zhai, Xuebing Cao

  • Open Access

    ATG14 ‐Mediated SNARE Complex Activation Promotes ΔFosB Degradation to Ameliorate Levodopa‐Induced Dyskinesia

    by Yi Wu, Ke Liu, Zhaoyuan Zhang, Zhuoran Ma, Zhicheng Tang, An Chang, Haoxuan Ouyang, Heng Zhai, Xuebing Cao, Yan Xu

    The chronic accumulation of ΔFosB in striatal medium spiny neurons has been implicated as a pivotal contributor to the pathogenesis of levodopa‐induced dyskinesia (LID). While recent studies have implicated autophagy in the degradation of ΔFosB and the amelioration of LID, the precise mechanisms remain elusive. We induced LID in a unilateral 6‐hydroxydopamine‐lesioned parkinsonism rat model via chronic levodopa treatment. To modulate the autophagy pathway, we overexpressed ATG14 in the striatum of LID rats and administered chloroquine, an autophagy inhibitor, peripherally. We assessed LID severity using abnormal involuntary movements (AIMs) scores. Western blotting, real‐time quantitative polymerase chain reaction, immunofluorescence, immunohistochemistry, transmission electron microscopy, and Golgi staining were employed to measure autophagy flux, synaptic alterations, and ΔFosB levels. Chronic levodopa treatment reduced ATG14 and SNARE complex (STX17, SNAP29, and VAMP8) levels, disrupted their interaction, impaired autophagy flux, affected synaptic function, and led to ΔFosB accumulation in the striatum of PD rats. Upregulating ATG14 in the striatum of LID rats improved AIMs scores, facilitated SNARE‐mediated autophagosome‐lysosome fusion, restored synaptic deficits, and promoted ΔFosB degradation. However, these beneficial effects of ATG14 upregulation were negated by chloroquine administration. Our findings suggest that upregulating ATG14 enhances SNARE formation, promoting autophagy flux and thereby reducing LID occurrence by facilitating ΔFosB degradation. image

  • Open Access

    Disruption of axonal transport in Parkinson’s disease: the role of pathological α-Syn and AMPK/p38 MAPK signaling

    by Xiaoman Yang, Zhuoran Ma, Piaopiao Lian, Yi Wu, Ke Liu, Zhaoyuan Zhang, Zhicheng Tang, Yan Xu, Xuebing Cao

    The accumulation of α-synuclein within Lewy bodies is a critical factor in the pathogenesis of Parkinson’s disease, with potential implications for axonal transport deficits. Activated asparagine endopeptidase enzymatically cleaves α-synuclein and tau, resulting in the formation of α-SynN103 and tauN368, which are markedly elevated in the brains with Parkinson’s disease. In this study, rats received intrastriatal injections of 15 µg of preformed α-SynN103 and tauN368 fibrils, and their behaviors were evaluated after a 2-month period. Subsequent analyses investigated alterations in axonal transport and the underlying molecular mechanisms. Our findings indicated that preformed fibrils reduced kinesin levels and excessively activated the AMPK and p38 MAPK, thereby compromising the function of kinesin and dynein in axonal transport. Pharmacological inhibition of AMPK and p38 MAPK ameliorated these dysfunctions in rat models, which identified Compound C and SB203580 as potent inhibitors, offering evidence for early interventions of Parkinson’s disease. Mechanisms by which PFFs caused axonal transport defects of dopamine neurons in PD-like models. (A) Shows normal axonal transport. (B) Demonstrates how PFFs increase ?-Syn accumulation, reducing PIKE expression and triggering AMPK/p38 MAPK over-activation, which lowers kinesin levels and motor-cargo interaction. (C) AMPK activity inhibition with C.C significantly improves these deficits. (D) The p38 inhibitor enhances kinesin transport by preventing p38 MAPK over-activation, reducing its inhibition of kinesin-cargo binding.


  • Open Access

    Alpha-synuclein Fibrils Inhibit Activation of the BDNF/ERK Signaling Loop in the mPFC to Induce Parkinson's Disease-like Alterations with Depression

    by Zhuoran Ma, Yan Xu, Piaopiao Lian, Yi Wu, Ke Liu, Zhaoyuan Zhang, Zhicheng Tang, Xiaoman Yang, Xuebing Cao

    Depression (Dep) is one of the most common concomitant symptoms of Parkinson's disease (PD), but there is a lack of detailed pathologic evidence for the occurrence of PD-Dep. Currently, the management of symptoms from both conditions using conventional pharmacological interventions remains a formidable task. In this study, we found impaired activation of extracellular signal-related kinase (ERK), reduced levels of transcription and translation, and decreased expression of brain-derived neurotrophic factor (BDNF) in the medial prefrontal cortex (mPFC) of PD-Dep rats. We demonstrated that the abnormal phosphorylation of α-synuclein (pS129) induced tropomyosin-related kinase receptor type B (TrkB) retention at the neuronal cell membrane, leading to BDNF/TrkB signaling dysfunction. We chose SEW2871 as an ameliorator to upregulate ERK phosphorylation. The results showed that PD-Dep rats exhibited improvement in behavioral manifestations of PD and depression. In addition, a reduction in pS129 was accompanied by a restoration of the function of the BDNF/ERK signaling loop in the mPFC of PD-Dep rats.


  • Open Access

    AMPK-mediated autophagy pathway activation promotes ΔFosB degradation to improve levodopa-induced dyskinesia

    by Ke Liu, Zhaoyuan Zhang, Yu Xu, Yi Wu, Piaopiao Lian, Zhuoran Ma, Zhicheng Tang, Xiaoqian Zhang, Xiaoman Yang, Heng Zhai, et al.


  • Open Access

    Identification of metabolism-related subtypes and feature genes in Alzheimer’s disease

    by Piaopiao Lian, Xing Cai, Cailin Wang, Ke Liu, Xiaoman Yang, Yi Wu, Zhaoyuan Zhang, Zhuoran Ma, Xuebing Cao, Yan Xu

    Background: Owing to the heterogeneity of Alzheimer's disease (AD), its pathogenic mechanisms are yet to be fully elucidated. Evidence suggests an important role of metabolism in the pathophysiology of AD. Herein, we identified the metabolism-related AD subtypes and feature genes. Methods: The AD datasets were obtained from the Gene Expression Omnibus database and the metabolism-relevant genes were downloaded from a previously published compilation. Consensus clustering was performed to identify the AD subclasses. The clinical characteristics, correlations with metabolic signatures, and immune infiltration of the AD subclasses were evaluated. Feature genes were screened using weighted correlation network analysis (WGCNA) and processed via Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses. Furthermore, three machine-learning algorithms were used to narrow down the selection of the feature genes. Finally, we identified the diagnostic value and expression of the feature genes using the AD dataset and quantitative reverse-transcription polymerase chain reaction (qRT-PCR) analysis. Results: Three AD subclasses were identified, namely Metabolism Correlated (MC) A (MCA), MCB, and MCC subclasses. MCA contained signatures associated with high AD progression and may represent a high-risk subclass compared with the other two subclasses. MCA exhibited a high expression of genes related to glycolysis, fructose, and galactose metabolism, whereas genes associated with the citrate cycle and pyruvate metabolism were downregulated and associated with high immune infiltration. Conversely, MCB was associated with citrate cycle genes and exhibited elevated expression of immune checkpoint genes. Using WGCNA, 101 metabolic genes were identified to exhibit the strongest association with poor AD progression. Finally, the application of machine-learning algorithms enabled us to successfully identify eight feature genes, which were employed to develop a nomogram model that could bring distinct clinical benefits for patients with AD. As indicated by the AD datasets and qRT-PCR analysis, these genes were intimately associated with AD progression. Conclusion: Metabolic dysfunction is associated with AD. Hypothetical molecular subclasses of AD based on metabolic genes may provide new insights for developing individualized therapy for AD. The feature genes highly correlated with AD progression included GFAP, CYB5R3, DARS, KIAA0513, EZR, KCNC1, COLEC12, and TST.


  • Activation of mGlu2/3 receptors in the striatum alleviates L-DOPA-induced dyskinesia and inhibits abnormal postsynaptic molecular expression

    by Yang Tan, Chi Cheng, Cong Zheng, Weiqi Zeng, Xiaoman Yang, Yu Xu, Zhaoyuan Zhang, Zhuoran Ma, Yan Xu, Xuebing Cao